Markets
Leaderboard
Will the Biosensors from NanoChemTech Solutions be approved for hospital and health settings use? Yes: real money —, play money 67% No: real money —, play money 33% Volume: real money 48.308015, play money 2246.3130054 Bettors: real money 0, play money 10 Categories: Science, Bioengineering Related markets Orion (a device that promises to project artificial vision into the brains of blind people) approved for sale by the end of 2027? (ID: 188268) Volume: real 229.73788695, play 28306.36245623 Bettors: real 8, play 42 Leading (real money): Orion (a device that promises to project artificial vision into the brains of blind people) approved 29% Leading (play money): Orion (a device that promises to project artificial vision into the brains of blind people) approved 16% Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? (ID: 209055) Volume: real 99.75069955, play 29620.78326599 Bettors: real 6, play 13 Leading (real money): Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? 9% Leading (play money): Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? 2%

Will the Biosensors from NanoChemTech Solutions be approved for hospital and health settings use?

Market Rules

A Brazilian technology startup, NanoChem Tech, has developed a biosensor capable of detecting infection-causing bacteria and fungi in beds, mattresses, doorknobs, and devices. Those surfaces can get contaminated with secretions from sick patients and become an important source of infection in hospital settings. The major concern that it tries to address in particular is the presence of antibiotic-resistant bugs.

The sensor works pretty much like a blood glucose monitoring device: you put a strip in contact with the surface, and a portable monitor makes the reading and gives the result in 30 minutes, revealing which bugs are present in the room. The time to have the result read is a breakthrough, as conventional microbiological analysis can take days to return a result.

As of July 2020, the company was testing the device in hospitals in the State of Sao Paulo. If by June 30, 2020, the biosensor from NanoChem Tech gets the sanitary approval (from ANVISA, Brazil's national health agency) to be used in hospitals, clinics, and/or manufacturing facilities, this market will be resolved as "yes".

Related Markets